Similar articles

• Plasma testosterone stimulation-suppression dynamics in hirsute women.

  Ettinger B, Von Werder K, Thenaers GC, Forsham PH. Ettinger B, et al. Am J Med. 1971 Aug;51(2):170-5. doi: 10.1016/0002-9343(71)90235-x. Am J Med. 1971. PMID: 4328775 No abstract available.
• Plasma testosterone in hirsute women: diagnostic significance of stimulation-suppression tests.

  von Werder K, Ettinger B, Thenaers GC, Forsham PH. von Werder K, et al. Acta Endocrinol Suppl (Copenh). 1971;152:16. Acta Endocrinol Suppl (Copenh). 1971. PMID: 5313534 No abstract available.
• Adrenocortical and ovarian function in the hirsute woman.

  Cooke CW, McEvoy D, Bulaschenko H, Wallach EE. Cooke CW, et al. Am J Obstet Gynecol. 1972 Sep 1;114(1):65-77. doi: 10.1016/0002-9378(72)90291-8. Am J Obstet Gynecol. 1972. PMID: 4344346 No abstract available.
• Pregnenolone, 17-OH-pregnenolone, and testosterone in plasma of patients with congenital adrenal hyperplasia.

  McKenna TJ, Jennings AS, Liddle GW, Burr IM. McKenna TJ, et al. J Clin Endocrinol Metab. 1976 May;42(5):918-25. doi: 10.1210/jcem-42-5-918. J Clin Endocrinol Metab. 1976. PMID: 178685 Clinical Trial.
• Virilizing adrenal adenoma.

  Mizutani S, Sonoda T, Matsumoto K. Mizutani S, et al. Am J Surg. 1973 Jul;126(1):114-6. doi: 10.1016/s0002-9610(73)80108-4. Am J Surg. 1973. PMID: 4351717 No abstract available.